Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP906976.RAWL7FbiAJmt2J9gWviucvc7eb1Xn9iYVhwkimM-NC7d4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP906976.RAWL7FbiAJmt2J9gWviucvc7eb1Xn9iYVhwkimM-NC7d4130_assertion type Assertion NP906976.RAWL7FbiAJmt2J9gWviucvc7eb1Xn9iYVhwkimM-NC7d4130_head.
- NP906976.RAWL7FbiAJmt2J9gWviucvc7eb1Xn9iYVhwkimM-NC7d4130_assertion description "[We measured plasma sHLA-G levels in 166 patients with early stages of colorectal cancer (CRC, n = 37), gastric cancer (GC, n = 28), esophageal squamous cell carcinoma (ESCC, n = 58) and non-small cell lung cancer (NSCLC, n = 43), and compared them to healthy controls (n = 260) by using a specific HLA-G enzyme-linked immunosorbent assay (ELISA).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906976.RAWL7FbiAJmt2J9gWviucvc7eb1Xn9iYVhwkimM-NC7d4130_provenance.
- NP906976.RAWL7FbiAJmt2J9gWviucvc7eb1Xn9iYVhwkimM-NC7d4130_assertion evidence source_evidence_literature NP906976.RAWL7FbiAJmt2J9gWviucvc7eb1Xn9iYVhwkimM-NC7d4130_provenance.
- NP906976.RAWL7FbiAJmt2J9gWviucvc7eb1Xn9iYVhwkimM-NC7d4130_assertion SIO_000772 21726203 NP906976.RAWL7FbiAJmt2J9gWviucvc7eb1Xn9iYVhwkimM-NC7d4130_provenance.
- NP906976.RAWL7FbiAJmt2J9gWviucvc7eb1Xn9iYVhwkimM-NC7d4130_assertion wasDerivedFrom befree-2016 NP906976.RAWL7FbiAJmt2J9gWviucvc7eb1Xn9iYVhwkimM-NC7d4130_provenance.
- NP906976.RAWL7FbiAJmt2J9gWviucvc7eb1Xn9iYVhwkimM-NC7d4130_assertion wasGeneratedBy ECO_0000203 NP906976.RAWL7FbiAJmt2J9gWviucvc7eb1Xn9iYVhwkimM-NC7d4130_provenance.